What does the FDA require to be labeled regarding certain therapies?

The correct choice indicates that the FDA requires labels to inform patients and healthcare providers about the potential for hyperglycemia and diabetes mellitus as a risk associated with certain therapies. This requirement stems from the recognition that some medications, particularly those used to treat various conditions such as mental health disorders or specific chronic illnesses, can significantly impact blood sugar levels.

Labeling this information is crucial because it helps ensure that patients are aware of the risks, allowing them to monitor their health effectively and make informed decisions in collaboration with their healthcare providers. Monitoring for hyperglycemia and diabetes is especially important for those individuals who may already be at risk or have pre-existing conditions that could be exacerbated by such medications.

By clearly stating these potential risks on labels, the FDA promotes patient safety and the proactive management of side effects, thereby enhancing therapeutic efficacy while minimizing adverse outcomes.